572 related articles for article (PubMed ID: 11431175)
1. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis.
Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
Am J Kidney Dis; 2002 May; 39(5):1054-60. PubMed ID: 11979350
[TBL] [Abstract][Full Text] [Related]
3. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M
J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162
[TBL] [Abstract][Full Text] [Related]
4. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese.
Thomas GN; Critchley JA; Tomlinson B; Lee ZS; Young RP; Cockran CS; Chan JC
Clin Nephrol; 2001 Jan; 55(1):7-15. PubMed ID: 11200871
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
[TBL] [Abstract][Full Text] [Related]
6. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
[TBL] [Abstract][Full Text] [Related]
7. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
8. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.
Ong-Ajyooth S; Ong-Ajyooth L; Limmongkon A; Tiensingh A; Parichatikanon P; Nilwarangkur S
J Med Assoc Thai; 1999 Jul; 82(7):681-9. PubMed ID: 10511770
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
[TBL] [Abstract][Full Text] [Related]
10. No association between the angiotensin-converting-enzyme gene insertion/deletion polymorphism and the occurrence of macroangiopathy in patients with diabetes mellitus type 2.
Klemm T; Mittrach-Schorin S; Neumann S; Gerike T; Krankenberg H; Schuler G; Paschke R
Horm Metab Res; 2003 Jan; 35(1):43-7. PubMed ID: 12669270
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
[TBL] [Abstract][Full Text] [Related]
14. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients.
Fradin S; Goulet-Salmon B; Chantepie M; Grandhomme F; Morello R; Jauzac P; Reznik Y
Diabetes Metab; 2002 Feb; 28(1):27-32. PubMed ID: 11938025
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes].
Liao L; Lei M; Han X; Chen H; Fan C
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):263-6. PubMed ID: 12016801
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system gene polymorphisms and premature coronary heart disease.
Sekuri C; Cam FS; Ercan E; Tengiz I; Sagcan A; Eser E; Berdeli A; Akin M
J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):38-42. PubMed ID: 16088850
[TBL] [Abstract][Full Text] [Related]
19. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
Ravn LS; Benn M; Nordestgaard BG; Sethi AA; Agerholm-Larsen B; Jensen GB; Tybjaerg-Hansen A
Pharmacogenet Genomics; 2008 Jun; 18(6):525-33. PubMed ID: 18496132
[TBL] [Abstract][Full Text] [Related]
20. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
